Prognostic value of CD4<sup>+</sup> in patients with Т1-2N0M0 breast cancer
Aim. To evaluate the prognostic value of CD4+ in patients with T1-2N0M0 breast cancer.Materials and methods. We performed a quantitative assessment of CD4+ T-lymphocytes in tumor stromal cells and determined the prognostic parameter using the method developed by us (patent No. RU2697709C1 dated 19.0...
Tallennettuna:
Päätekijät: | , , , , |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
ABV-press,
2023-08-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
Hyllypaikka: |
A1234.567 |
---|---|
Nide 1 | Saatavissa |